{"id":"W4411017094","doi":"10.1016/j.tjpad.2025.100205","title":"Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease","year":2025,"lang":"en","type":"article","venue":"The Journal of Prevention of Alzheimer s Disease","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; McGill University; Douglas Mental Health University Institute","funders":"H2020 Marie Skłodowska-Curie Actions; Fonds de Recherche du Québec - Santé; Horizon 2020 Framework Programme; Olav Thon Stiftelsen; Emil och Wera Cornells Stiftelse; Instituto Serrapilheira; National Research Foundation of Korea; Ministry of Science and ICT, South Korea; Ministry of Health and Welfare; Conselho Nacional de Desenvolvimento Científico e Tecnológico; University College London; Korea Health Industry Development Institute; National Institute on Aging; National Institute for Health and Care Research; EU Joint Programme – Neurodegenerative Disease Research; Alzheimer's Association; Stiftelsen för Gamla Tjänarinnor; Familjen Erling-Perssons Stiftelse; Korea Disease Control and Prevention Agency; Vetenskapsrådet; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; National Academy of Neuropsychology; Alzheimerfonden; Weston Brain Institute; Alzheimer's Drug Discovery Foundation; Canadian Institutes of Health Research; Instituto de Ciência e Tecnologia de Nanomateriais de Carbono","keywords":"Disease; Alzheimer's disease; Clinical trial; Clinical endpoint; Medicine; Endpoint Determination; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1383429,0.001157564,0.00303095,0.001246347,0.0006098929,0.002470698,0.001014895,0.001948109,0.001723987],"category_scores_gemma":[0.1384797,0.0003869708,0.003950864,0.001394275,0.001247122,0.001735394,0.001085529,0.00236797,0.0003462505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009729216,"about_ca_system_score_gemma":0.001780151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002180663,"about_ca_topic_score_gemma":0.0003231486,"domain_scores_codex":[0.8414658,0.1424017,0.007144629,0.002756494,0.005583958,0.0006473362],"domain_scores_gemma":[0.775508,0.1594454,0.03945676,0.009698492,0.01322727,0.002663963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5825902,0.003183077,0.1403039,0.009199394,0.02992496,0.000331062,0.0007804684,0.008285805,0.00733929,0.003139818,0.004964793,0.2099571],"study_design_scores_gemma":[0.1655058,0.3127928,0.4012515,0.00285144,0.02920748,0.0009213248,0.0003080266,0.03462765,0.01231912,0.01421477,0.02569382,0.0003061877],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8364958,0.05883037,0.05995535,0.00527777,0.002113731,0.01885673,0.004105391,0.0005278246,0.01383701],"genre_scores_gemma":[0.9709734,0.001840708,0.01435127,0.0008025838,0.0005310677,0.01027432,0.0006997413,0.00004380436,0.0004831573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1383429,"threshold_uncertainty_score":0.731636,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1875187441713972,"score_gpt":0.4893173829288177,"score_spread":0.3017986387574205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}